Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.

GLP-1 drugs like Ozempic may lower the risk of obesity-related cancers, particularly colorectal cancer, among type 2 diabetes ...

Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of ...

Recent studies suggest that popular weight loss drugs like Ozempic may offer surprising anti-cancer benefits, particularly ...

Game-changing weight loss jabs could help ward off up to 14 types of cancer, world-leading experts suggest. Mounjaro, Ozempic and other ... such as slashing the risk of heart attacks, strokes ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Being overweight or obese is the second biggest cause of cancer in the UK, causing more than one in 20 cancer cases, ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...